NHGRI logo

NHGRI publishes new strategic vision for human genomics

Eric Green, M.D., Ph.D. November 05, 2020

October was a particularly busy (and exciting) month for NHGRI. In addition to celebrating the 30th anniversary of the launch of the Human Genome Project (HGP), which was featured in last month’s The Genomics Landscape, the institute also published the 2020 NHGRI Strategic Vision. This paper is the culmination of the Genomics2020 Strategic Planning Process, which NHGRI initiated in early 2018. My profound thanks to many of you, both inside and outside of the institute, who contributed to these two huge endeavors. I hope you find the paper to provide a compelling and informative vision for human genomics in the coming decade.

I would also like to draw your attention to the social media stories that NHGRI developed for the 30th anniversary of the HGP launch. This included video testimonials about the HGP from many different genomics and genetics researchers. This collection, which continues to grow after its previous highlight in last month’s The Genomics Landscape, is available on the NHGRI YouTube channel, GenomeTV. I encourage you to check out our newest additions.

All the best,
Eric Green signature

NHGRI publishes new strategic vision for human genomics

Four themes of the strategic vision

 

NHGRI has an established history of conducting strategic planning processes that first engage the genomics community and then produce published strategic visions. These routines were first implemented in collaboration with the other funders associated with the Human Genome Project. Following completion of the Project, NHGRI began developing its own strategic visions — the first in 2003 and the second in 2011 — and they have provided invaluable blueprints for the institute’s pursuits over the past ~17 years. Last week, the institute added the third chapter to this series, publishing the 2020 NHGRI Strategic Vision (entitled Strategic vision for improving human health at The Forefront of Genomics ) in the journal Nature. This paper is the result of an extensive ~32-month strategic planning process that involved thousands of individuals. It provides a "2020 vision" for human genomics for the coming decade.

Each of the three NHGRI-produced strategic visions is quite distinct, reflecting different eras and circumstances for genomics as a field and for NHGRI as a research funder. With genomics now being deeply woven into the fabric of biomedical research and, increasingly, medicine and society, developing the 2020 NHGRI Strategic Vision required deeper and broader engagement, not just with researchers but also with healthcare professionals and multiple other communities. In the end, the latest round of strategic planning involved over 50 events, including workshops focused on specific areas and town halls across the country that involved diverse stakeholders; the process also included extensive discussions with NHGRI’s advisory groups.

The 2020 NHGRI Strategic Vision acknowledges the highly disseminated nature of genomics that the field will encounter this decade. While genomics was once a fairly confined field, new technologies and advances have catalyzed significant uptake of genomics throughout biomedical research and into other areas such as healthcare, agriculture, ancestry testing, and forensics. Meanwhile, the genomics funding ecosystem at NIH has also changed. During the Human Genome Project, NHGRI funded more than 95% of the “human genomics” research supported by NIH. Now, this figure is roughly 10%, meaning that the other NIH institutes and centers have embraced the study of human genomics in a significant way across their research portfolios and now fund the remaining ~90% of human genomics research. NHGRI has a new role in this dynamic landscape, with a shift from leading almost all of human genomics to a focus on the most cutting-edge aspects of the field — that is, The Forefront of Genomics.

The 2020 NHGRI Strategic Vision recognizes that responsible stewardship is a central aspect of being at (and pushing forward) The Forefront of Genomics, specifically in four major areas:

  • The first, “guiding principles and values for human genomics,” undergirds the entire field by being cognizant of important issues related to things like diversity, equity, social justice, data sharing, and team science.
  • The second, “sustaining and improving a robust foundation for genomics,” represents the reliance of the broader biomedical enterprise on a strong foundation for genomics research (consisting of infrastructure, resources, training, genomic literacy, data science, and exciting areas of technology development) and the need to sustain and improve this foundation.
  • The third, “breaking down barriers that impede progress in genomics,” is a call-to-action for high-risk pursuits to eliminate obstacles related to DNA synthesis and editing, characterizing genomic variants, understanding genomic mosaicism, and implementation science.
  • The fourth, “compelling genomics research projects in biomedicine,” aims to stretch our imagination and pique our curiosity through audacious studies that will provide new insights into areas such as genome function, the genetic architecture of human diseases and traits, and genomic medicine implementation.

 

The 2020 NHGRI Strategic Vision culminates with 10 bold predictions for human genomics by 2030. Crafted to be both inspirational and aspirational, these predictions are intended to provoke thoughtful discussions (and even debate) about what might be possible in the coming decade. Among the boldest of the 10 predictions are those that rely not only on the tools of genomics, but also on advances in society — a reminder that the science can only take us so far. These 10 bold predictions are featured in an NHGRI-produced video, narrated by the talented author and NHGRI friend, Siddhartha Mukherjee, M.D., Ph.D.

Through its focus on The Forefront of Genomics, the new strategic vision aims to convey the areas that are most appropriate for NHGRI’s vision, leadership, and responsible stewardship. That spirit is further amplified in an accompanying commentary written by NHGRI Director Eric Green in Scientific American. To fulfill the full potential of genomics, researchers need to push the boundaries of science at the same time that each person — scientist and nonscientist alike — continually examines what they know to be true and possible.

The 2020 NHGRI Strategic Vision is available online at genome.gov/2020SV.

NIH study examines genomic contributions to COVID-19 symptoms

Virus

 

In early 2020, NHGRI, the National Cancer Institute (NCI), and National Institute of Allergy and Infectious Diseases (NIAID) launched a collaborative study in response to the COVID-19 pandemic. This study aims to learn about the genomic contributions that influence the severity of COVID-19 symptoms. People who have tested positive for SARS-CoV-2 (the virus that causes COVID-19) may be eligible. Participants will be asked to donate a small amount of blood and answer questions about their health history and COVID-19 symptoms. Results from this study may provide insights for use in reducing the severity of COVID-19 symptoms and, potentially, for developing new therapies. Please visit genome.gov/covidcode for more information.

NIH encourages participation in surveys to identify impacts of COVID-19 on grantee research

Pen

 

NIH has issued two surveys to gather data on how COVID-19 affects extramural grantee researchers and their institutions. Responses are confidential and anonymous, and all questions are optional. NIH is working to create a plan for how and when to share results. The first survey aims to understand overall challenges faced by NIH-funded institutions during the COVID-19 pandemic. A single institutional leader who oversees research at the institutions in the sampling population received an email from Michael Lauer, NIH Deputy Director for Extramural Research, with an invitation to take the survey. The institutional survey closes on November 6. The second survey aims to understand the impact of COVID-19 on individual researchers at NIH-funded institutions. Researchers in the sampling population received an email from Qualtrics with an invitation to take the survey. The researcher survey closes on November 13. Grantees who have received these emails are encouraged to respond. The results of the surveys will inform policy and program decisions as NIH seeks ways to continue supporting the biomedical research enterprise during the pandemic.

  • NIH encourages participation in surveys to identify impacts of COVID-19 on grantee research
    Pen

     

    NIH has issued two surveys to gather data on how COVID-19 affects extramural grantee researchers and their institutions. Responses are confidential and anonymous, and all questions are optional. NIH is working to create a plan for how and when to share results. The first survey aims to understand overall challenges faced by NIH-funded institutions during the COVID-19 pandemic. A single institutional leader who oversees research at the institutions in the sampling population received an email from Michael Lauer, NIH Deputy Director for Extramural Research, with an invitation to take the survey. The institutional survey closes on November 6. The second survey aims to understand the impact of COVID-19 on individual researchers at NIH-funded institutions. Researchers in the sampling population received an email from Qualtrics with an invitation to take the survey. The researcher survey closes on November 13. Grantees who have received these emails are encouraged to respond. The results of the surveys will inform policy and program decisions as NIH seeks ways to continue supporting the biomedical research enterprise during the pandemic.

NHGRI Short Course in Genomics engages educators and students at all levels

Short course

 

Members of NHGRI’s Education and Community Involvement Branch recently published a paper, entitled “The NHGRI Short Course in Genomics: energizing genetics and genomics education in classrooms through direct engagement between educators and scientists,” in the journal Genetics in Medicine. Through comparison of publicly available NHGRI Short Course participant data from 2015 to 2019 with data from the National Center for Education Statistics, the authors assessed progress in serving diverse educator and student populations. The paper concludes that the NHGRI Short Course has the potential to facilitate the engagement of educators and students at all levels, inform the public about recent advances, recruit and maintain a diverse STEM workforce, and improve genomic literacy and future health decision-making. Although the course focuses on genomics, the framework and lessons are transferrable to other scientific areas, especially for institutions with active research programs.

H3Africa genomics study informs understanding of human migration and health

Art

 

Last month, the Human Heredity and Health in Africa (H3Africa) Consortium published a major paper in the journal Nature reporting results from their efforts to increase genomic data from African populations. The paper, entitled “High depth African genomes inform human migration and health,” includes the analyses of whole-genome sequences of 426 individuals from 13 African countries, which together represent 50 ethnolinguistic ancestral groups. The findings show complex patterns of admixture, putative-damaging and novel variation, and clinically relevant genomic markers. The study discovered 62 new genomic regions under strong selection, with many of the regions containing genes involved in viral immunity. The effort was primarily led by African researchers from multiple African countries working with collaborators and institutions from outside Africa. H3Africa is an initiative led by NIH, the Wellcome Trust, and the African Society of Human Genetics that aims to enhance genomics research on the African continent through research, training, and infrastructure development.

NIH-ACMG fellowship for training leaders in genomic medicine program management

Patient form

 

In 2017, NIH and the American College of Medical Genetics and Genomics (ACMG) established a fellowship in genomic medicine program management. This two-year opportunity aims to increase the pool of healthcare practitioners who are trained to lead research and implementation programs in genomic medicine. The fellowship is a partnership between the ACMG and four components of the NIH: NHGRI; the National Heart, Lung, and Blood Institute (NHLBI); the National Institute on Minority Health and Health Disparities (NIMHD); and the All of Us Research Program. Four fellows are currently participating in the program: 2019-2021 fellows Hwaida Hannoush, M.D., FASE and Marie-Luise Brennan, M.D., Ph.D.; and 2020-2022 fellows Renee Rider, J.D., M.S. and Valerie Willis, Ph.D., R.N., PPCNP-BC, PCNS-BC. Applications for the 2021-2023 fellowship are due on December 1, 2020.

Nobel Prize in Chemistry awarded for CRISPR genome-editing technology

Jennifer Doudna

 

This year’s Nobel Prize in Chemistry was awarded to Jennifer Doudna, Ph.D., and Emmanuelle Charpentier, Ph.D., for their groundbreaking work in genome editing and the development of the CRISPR-Cas9 system. The tools developed through the CRISPR-Cas9 system are being used across the full continuum of biomedical research, with basic, translational, and clinical applications. Dr. Doudna leads the NHGRI-funded Center for Genome Editing and Recording (CGER), part of the institute’s Centers of Excellence in Genomic Science (CEGS) program. CGER aims to address the need to study the human genome at higher resolution and with increased accuracy, specifically by developing tools based on CRISPR-Cas9 systems to study and modify genome sequences in various cells and tissues.

NHGRI Deputy Scientific Director receives HHS Leadership Award

Paul Liu



Paul Liu, M.D., Ph.D., NHGRI’s deputy scientific director and senior investigator in NHGRI’s Translational and Functional Genomics Branch, was recently awarded the 2020 Dr. Howard K. Koh Award for Excellence in Leadership at the Department of Health and Human Services (HHS). The Koh Award recognizes an employee from the Asian American/Native Hawaiian/Pacific Islander (AANHPI) community who exemplifies outstanding leadership, service integrity, and excellence, and who has significantly contributed to the HHS mission. Dr. Liu shares this year’s Koh Award with Dr. Robin M. Ikeda, associate director for policy and strategy at the Centers for Disease Control and Prevention.

2020 NHGRI Strategic Vision

Learn More
2020 Strategic Vision -

Related Resources

Genomics Research

As genome-editing trials become more common, informed consent is changing

Scientists use gene therapy and a novel light-sensing protein to restore vision in mice

Scientists use clues in the human genome to discover new inflammatory syndrome

High depth African genomes inform human migration and health

Notable accomplishments in genomic medicine

COVID-19 News and Research

NIH to assess and expand COVID-19 testing for underserved communities

COVID-19 can damage hearts of some college athletes

Rogue antibodies and gene mutations explain some cases of severe COVID-19

NIH to launch the Serological Sciences Network for COVID-19, announce grant and contract awardees

NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 begins

NIH study aims to identify promising COVID-19 treatments for larger clinical trials

COVID-19 vaccine appears well-tolerated and effective in developing antibodies in small study of older adults

Building resilience during the COVID-19 pandemic

NIH begins large clinical trial to test immune modulators for treatment of COVID-19

Dr. Collins joins Skimm This podcast to discuss COVID-19 vaccine timelines and staying vigilant about COVID-19 safety guidelines

Two studies show COVID-19 antibodies persist for months

Dr. Collins talks to CNN’s Wolf Blitzer about the recent increase in COVID-19 cases and the importance of wearing a face covering

Dr. Anthony Fauci and Dr. Collins provide an update on COVID-19 vaccine research

Dr. Collins speaks with NCATS Dr. Christopher Austin on new NIH clinical trial to test immune modulators for treatment of COVID-19

Study highlights need for continued care of COVID-19 survivors

Protein mapping study reveals valuable clues for COVID-19 drug development

NIH scientists discover key pathway in lysosomes that coronaviruses use to exit cells

Dr. Collins join’s SiriusXM’s Doctor Radio to provide an update on COVID-19 therapeutics, testing, vaccine development, and more

Dr. Collins participates in the National Press Club’s Virtual Newsmaker series

A guest on the Dr. Oz Show, Dr. Collins expresses concern over the colder weather leading to indoor gathering and the rise of COVID-19 cases

Drs. Collins and Fauci provide an update on COVID-19 vaccine research during a Facebook and Twitter live event

Dr. Collins addresses children participating in COVID-19 vaccine clinical trials with CNBC’s Shepard Smith

Genomics Videos

The Future of Genomics: 10 Bold Predictions

2020 NHGRI Short Course in Genomics

HGP 30th anniversary video testimonials

2020 ENCODE research applications and users meeting

Funding Opportunities

Administrative supplements to existing NIH grants and cooperative agreements

Utilizing in vitro functional genomics advances for gene-environment (G x E) discovery and validation

Ruth L. Kirschstein National Research Service Award (NRSA) individual predoctoral fellowship

Clarification of the objectives and program elements in NHGRI applications submitted in response to the "Ruth L. Kirschstein (NRSA) institutional research training grants”

Clarification of the role of the intramural investigator in “Opportunities for collaborative research at the NIH Clinical Center”

Notice of change to receipt date for NHGRI synthetic nucleic acid technology development FOAs

Discovery of the genetic basis of childhood cancers and of structural birth defects: Gabriella Miller Kids First pediatric research program

NHGRI funding opportunities overview

Funding News

NIH operates under a continuing resolution

Notice of clarification: Policy for managing conflict of interest in NIH peer review

NIH & NHGRI News

NHGRI publishes new vision for human genomics

Statement on Final NIH Policy for Data Management and Sharing

Dr. Harvey Alter wins 2020 Nobel Prize in Physiology or Medicine

NIH to support 85 new grants featuring high-risk, high-reward research

Dr. Collins joins 2020 Nobel Laureate in Chemistry Dr. Jennifer Doudna for a conversation on CRISPR, gene editing & more

All of Us expands enrollment and engagement efforts with new awardees

Genome: Unlocking Life's Code October 2020 newsletter

Genome: Unlocking Life's Code

Traveling Exhibit Schedule
Woman made of ACTGs
grey dot pattern

About The Genomics Landscape

A monthly update from the NHGRI Director on activities and accomplishments from the institute and the field of genomics.

grey dot pattern

Last updated: December 2, 2020